What are ClearPoint Neuro's total assets?

ClearPoint Neuro (CLPT) holds $93.4M in total assets, up 210.7% year over year.

How much debt does ClearPoint Neuro have?

ClearPoint Neuro carries $63.6M in total debt against $18.8M of shareholders' equity, a debt-to-equity ratio of 3.38.

How much cash does ClearPoint Neuro have?

ClearPoint Neuro holds $36.5M in cash and equivalents.

Can ClearPoint Neuro cover its short-term obligations?

Its current ratio is 5.79 — current assets exceed current liabilities.

Where does ClearPoint Neuro's balance sheet data come from?

Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ClearPoint Neuro CLPT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$46.97M+134%	$20.1M-13.1%	$23.14M-16.2%	$27.62M-49.0%
Restricted cash	——	——	——	——
Accounts receivable, net	$6.55M+39.0%	$4.71M+46.8%	$3.21M+20.5%	$2.67M+14.0%
Inventories	$8.36M+8,016%	$103K-73.3%	$386K-14.2%	$450K-13.3%
Raw materials	$7.05M+28.1%	$5.5M—	——	——
Finished goods	$4.81M+33.0%	$3.62M+193%	$1.23M-52.2%	$2.58M+28.4%
Prepaid expenses and other current assets	$2.77M+64.5%	$1.68M-11.9%	$1.91M+10.9%	$1.72M+239%
Contract assets	$150K—	$0—	$0-100%	$300K—
Total current assets	$63.6M+90.6%	$33.36M-7.8%	$36.17M-29.3%	$51.18M-17.3%
Property and equipment, net	$2.62M+30.7%	$2.01M+44.3%	$1.39M+72.3%	$806K+49.5%
Accumulated depreciation	——	——	——	——
Operating lease right-of-use assets	$8.43M+173%	$3.09M-13.4%	$3.56M+88.1%	$1.9M-15.4%
Goodwill	$7.47M0.0%	$7.47M—	——	——
Intangible assets, net	$13.92M—	$0—	——	——
Deferred tax assets	$354K—	$0—	——	——
Other non-current assets	$1.7M+132%	$735K+574%	$109K-16.8%	$131K+4.8%
Total assets	$97.75M+149%	$39.19M-8.1%	$42.66M-23.1%	$55.49M-15.4%
Accounts payable	$1.26M-6.3%	$1.34M+241%	$393K+44.5%	$272K-36.3%
Accrued expenses	$4.36M-10.7%	$4.89M+65.8%	$2.95M+4.4%	$2.82M+8.4%
Deferred revenue	$1.67M-21.3%	$2.12M-32.8%	$3.15M+709%	$390K+47.7%
Operating lease liabilities, current	$694K+24.6%	$557K+31.4%	$424K-24.4%	$561K+10.7%
Contract liabilities	$581K+33.3%	$436K-86.2%	$3.15M—	——
Total current liabilities	$10.77M+4.0%	$10.35M+39.3%	$7.43M+9.5%	$6.79M+42.8%
Long-term debt	$49.08M—	$0-100%	$9.95M+0.6%	$9.89M+0.6%
Operating lease liabilities, non-current	$8.46M+181%	$3.01M-15.6%	$3.57M+133%	$1.53M-21.0%
Operating Lease Liabilities (Total)	$9.16M+157%	$3.57M-10.6%	$3.99M+90.7%	$2.09M-14.4%
Other non-current liabilities	$489K—	$0—	——	——
Total liabilities	$69.73M+405%	$13.8M-35.8%	$21.49M+15.5%	$18.6M+10.8%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	90M+32,509%	276K+11.7%	247K-99.9%	200M+84,288%
Additional paid-in capital	$239M+10.4%	$216.48M+11.9%	$193.38M+3.4%	$187.01M+2.5%
Retained earnings	-$216.91M-13.3%	-$191.37M-11.0%	-$172.46M-14.7%	-$150.37M-12.3%
Total stockholders' equity	$28.02M+10.4%	$25.39M+19.9%	$21.17M-42.6%	$36.89M-24.4%
Total liabilities and stockholders' equity	$97.75M+149%	$39.19M-8.1%	$42.66M-23.1%	$55.49M-15.4%
Allowance for Doubtful Accounts	$1.2M+9.1%	$1.1M-21.4%	$1.4M+1,300%	$100K-66.7%
Allowance for Doubtful Accounts Receivable (Current)	$1.2M+9.1%	$1.1M-21.4%	$1.4M+1,300%	$100K-66.7%
Other Inventory, Net	$3.51M+55.2%	$2.26M—	——	——
Deferred Tax Assets and Other Non-Current Assets	$1.7M+132%	$735K+574%	$109K-16.8%	$131K+4.8%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——
Finite Lived Intangible Assets - Gross	——	——	——	——
Net Investment in Lease	$8.43M+173%	$3.09M-13.4%	$3.56M+88.1%	$1.9M-15.4%
Intangible assets — net	——	——	——	——
Other intangible assets—net	$13.92M—	$0—	——	——
Operating lease right-of-use assets	$8.43M+173%	$3.09M-13.4%	$3.56M+88.1%	$1.9M-15.4%
Other non-current assets	$1.7M+132%	$735K+574%	$109K-16.8%	$131K+4.8%
Operating Lease Right-of-Use Assets in Other Assets	$8.43M+173%	$3.09M-13.4%	$3.56M+88.1%	$1.9M-15.4%
Software and Technology Licenses, Net	$1.7M+132%	$735K+574%	$109K-16.8%	$131K+4.8%
Accrued Manufacturing Costs	$4.36M-10.7%	$4.89M+65.8%	$2.95M+4.4%	$2.82M+8.4%
Accrued Progress Collections and Price Adjustments	$581K+33.3%	$436K—	——	——
Compensation and benefits	$4.36M-10.7%	$4.89M+65.8%	$2.95M+4.4%	$2.82M+8.4%
Contract Liabilities, Non-Current	$581K+33.3%	$436K—	——	——
Debt Maturity - Thereafter	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	——	——	——	——
Deferred revenue, net of current portion	$581K+33.3%	$436K—	——	——
Total debt	$58.23M+1,532%	$3.57M-74.4%	$13.94M+16.3%	$11.99M-2.4%
Total Carrying Value of Debt	——	——	——	——
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	29.4M+6.3%	27.6M+12.0%	24.7M+0.3%	24.6M+3.9%
Common Stock Shares Outstanding	——	——	——	——
Convertible Preferred Stock Authorized Shares	25M0.0%	25M0.0%	25M0.0%	25M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Additional paid-in capital	$239M+10.4%	$216.48M+11.9%	$193.38M+3.4%	$187.01M+2.5%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$294K+6.5%	$276K+11.7%	$247K+0.4%	$246K+3.8%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Number of Exercisable Options	——	——	——	——
Preferred Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Share-Based Payment Award Options Outstanding - Number	1.3M-5.4%	1.4M-6.9%	1.5M+5.7%	1.4M+3.5%
Weighted Average Exercise Price of Outstanding Options	$5.78-10.8%	$6.48-22.9%	$8.40-3.3%	$8.69-14.0%
Accounts Receivable, Allowance for Credit Loss	$1.2M+9.1%	$1.1M-21.4%	$1.4M+1,300%	$100K-66.7%
Uninsured amount	——	——	——	——
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$90M0.0%	$90M0.0%	$90M-55.0%	$200M0.0%
Common stock, shares issued (in shares)	$29.37M+6.3%	$27.62M+12.0%	$24.65M+0.3%	$24.58M+3.9%
Common Stock, Shares, Outstanding	$29.37M+6.3%	$27.62M+12.0%	$24.65M+0.3%	$24.58M+3.9%
Common Stock Shares Subscriptions	$5.64M—	$0—	——	——
Contract with Customer, Liability	$2.25M-12.0%	$2.56M-18.9%	$3.15M—	——
Long-term debt, gross	——	——	——	——
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	——	——	——	——
Deferred income taxes	$354K—	$0—	——	——
Finite Lived Intangible Asset Expected Amortization After Year Four	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	——	——	——	——
2028	——	——	——	——
2030	——	——	——	——
Remainder of 2026	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Gross Carrying Amount	——	——	——	——
Work-in-process and raw materials	$7.05M+28.1%	$5.5M—	——	——
Thereafter	——	——	——	——
Long Term Notes Payable	$49.08M—	$0—	——	——
Number Of Customers	——	——	——	——
Other accrued liabilities	$2.79M+92.1%	$1.45M+37.7%	$1.05M-49.0%	$2.07M+285%
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	$25M0.0%	$25M0.0%	$25M0.0%	$25M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$1.3M-5.4%	$1.38M-6.9%	$1.48M+5.7%	$1.4M+3.5%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$5.78-10.8%	$6.48-22.9%	$8.4-3.3%	$8.69-14.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——
Unbilled balances	$714K+11.2%	$642K-12.4%	$733K—	——
Remainder of Fiscal Year 2024	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ClearPoint Neuro.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Questions, answered.

What are ClearPoint Neuro's total assets?: ClearPoint Neuro (CLPT) holds $93.4M in total assets, up 210.7% year over year.
How much debt does ClearPoint Neuro have?: ClearPoint Neuro carries $63.6M in total debt against $18.8M of shareholders' equity, a debt-to-equity ratio of 3.38.
How much cash does ClearPoint Neuro have?: ClearPoint Neuro holds $36.5M in cash and equivalents.
Can ClearPoint Neuro cover its short-term obligations?: Its current ratio is 5.79 — current assets exceed current liabilities.
Where does ClearPoint Neuro's balance sheet data come from?: Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.